MM

Mahendiran Menaka

Active Director Director DIN 10664212
DIN 10664212 First appointment Jun 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Mahendiran Menaka

Data last updated:

Mahendiran Menaka is a Director at Edris Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10664212
Primary Designation Director
Industry Pharma
First Appointment 11 Jun 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Jun 20242024Active

Board colleagues of Mahendiran Menaka

NameDINCompanyDesignation
Moorthy Muniyappan10664213Edris Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Edris Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mahendiran Menaka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahendiran Menaka

Mahendiran Menaka currently holds 1 directorship: Edris Pharmaceuticals Private Limited (Director, since 11 Jun 2024).

Mahendiran Menaka was first appointed on 11 Jun 2024 as Director at Edris Pharmaceuticals Private Limited.

The current boards of Mahendiran Menaka's companies include Moorthy Muniyappan (Edris Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available